We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+11.76%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.08B
AUM Growth
+$20.7M
Cap. Flow
-$60.6M
Cap. Flow %
-5.62%
Top 10 Hldgs %
20.95%
Holding
208
New
36
Increased
50
Reduced
44
Closed
33

Top Buys

Rank Stock Value
1
CYTK icon
Cytokinetics
CYTK
+$22.8M
2
LEGN icon
Legend Biotech
LEGN
+$18.8M
3
DAWN
Day One Biopharmaceuticals
DAWN
+$16.1M
4
SWTX
SpringWorks Therapeutics
SWTX
+$16M
5
UTHR icon
United Therapeutics
UTHR
+$15.2M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$20M
2
HQY icon
HealthEquity
HQY
+$18.6M
3
ESI icon
Element Solutions
ESI
+$17.4M
4
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$14.2M
5
RARE icon
Ultragenyx Pharmaceutical
RARE
+$13.7M

Sector Composition

Rank Sector Weight
1 Healthcare 44.2%
2 Technology 15.96%
3 Industrials 9.72%
4 Energy 6.59%
5 Consumer Staples 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WING icon
51
Wingstop
WING
$3.18B
$7.71M 0.71%
+61,458
New +$7.35M
WCN
52
Waste Connections
WCN
$42B
$7.68M 0.71%
56,832
+10,459
+23% +$1.43M
WTFC icon
53
Wintrust Financial
WTFC
$10.7B
$7.45M 0.69%
91,319
+7,502
+9% +$637K
KKR.PRC
54
DELISTED
KKR & Co. Inc. 6.00% Series C Mandatory Convertible Preferred Stock
KKR.PRC
– –
0
– –
GS icon
55
Goldman Sachs
GS
$303B
$6.79M 0.63%
23,157
+4,657
+25% +$1.51M
CRWD icon
56
CrowdStrike
CRWD
$218B
$6.7M 0.62%
162,668
– –
BAC icon
57
Bank of America
BAC
$442B
$6.64M 0.62%
220,000
-40,000
-15% -$1.34M
GOOG icon
58
Alphabet (Google) Class C
GOOG
$4.32T
$6.6M 0.61%
68,621
+14,721
+27% +$1.64M
VICI icon
59
VICI Properties
VICI
$29.4B
$6.09M 0.56%
203,934
+161,434
+380% +$5.33M
ARES icon
60
Ares Management
ARES
$30.9B
$5.95M 0.55%
96,105
– –
GTLS
61
DELISTED
Chart Industries
GTLS
$5.92M 0.55%
32,131
+6,994
+28% +$1.3M
MGPI icon
62
MGP Ingredients
MGPI
$375M
$5.85M 0.54%
55,080
+4,965
+10% +$533K
AVGO icon
63
Broadcom
AVGO
$2.04T
$5.79M 0.54%
130,420
+116,980
+870% +$5.98M
BX icon
64
Blackstone
BX
$110B
$5.69M 0.53%
67,990
+1,260
+2% +$122K
DSGX icon
65
Descartes Systems
DSGX
$6.82B
$5.68M 0.53%
89,402
+3,567
+4% +$242K
GOSS icon
66
Gossamer Bio
GOSS
$87M
$5.62M 0.52%
+469,317
New +$5.83M
AMRC icon
67
Ameresco
AMRC
$1.36B
$5.59M 0.52%
84,074
-49,277
-37% -$3.03M
FNKO icon
68
Funko
FNKO
$328M
$5.57M 0.52%
+275,460
New +$6.31M
TSLA icon
69
Tesla
TSLA
$1.3T
$5.5M 0.51%
20,733
+16,329
+371% +$4.56M
SNPS icon
70
Synopsys
SNPS
$79.7B
$5.45M 0.51%
17,841
+983
+6% +$333K
CWST icon
71
Casella Waste Systems
CWST
$5.69B
$5.44M 0.5%
+71,251
New +$5.71M
WMB icon
72
Williams Companies
WMB
$86.1B
$5.41M 0.5%
189,000
– –
CDNS icon
73
Cadence Design Systems
CDNS
$93.4B
$5.4M 0.5%
33,023
+4,522
+16% +$778K
AMZN icon
74
Amazon
AMZN
$2.96T
$5.11M 0.47%
45,242
-938
-2% -$119K
KRNT icon
75
Kornit Digital
KRNT
$791M
$4.98M 0.46%
186,980
-65,682
-26% -$1.89M
1 2
3
4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Nicholas Investment Partners held 208 positions worth $1.08B, up 2% from $1.06B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nicholas Investment Partners withdrew a net $60.6M in Q3 2022, closing 33 positions and reducing 44 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $20M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 41% a quarter earlier, followed by Technology and Industrials.

Against the trend, Nicholas Investment Partners opened a new position in Cytokinetics worth $22.9M.

  • Nicholas Investment Partners's largest Q3 2022 buy was Cytokinetics: 472,839 shares worth $22.9M.
  • Nicholas Investment Partners added most to Callaway Golf Company in Q3 2022, an estimated $9.5M increase.
  • Nicholas Investment Partners's biggest Q3 2022 reduction was IVERIC bio, Inc. Common Stock, cutting an estimated $14.2M.
  • Nicholas Investment Partners fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $20M.
  • Nicholas Investment Partners's ten largest holdings make up 21% of its $1.08B portfolio in Q3 2022.
  • Nicholas Investment Partners opened 36 new positions and closed 33 in Q3 2022.
  • Nicholas Investment Partners's portfolio value rose 2% quarter-over-quarter to $1.08B.

Based on Nicholas Investment Partners's 13F filing for Q3 2022, filed 14 Nov 2022.